Immunotherapy for Conjunctival Squamous Cell Carcinoma with Orbital Extension.

Abstract Immune checkpoint inhibitors were effective and well tolerated in advanced conjunctival squamous cell carcinoma with orbital extension. Of five tumors, four with high mutation burden showed complete and durable response after a mean follow-up of 6 months.